A cohort study of cancer incidence in systemic sclerosis

Journal of Rheumatology

Volumn 33, Issue 6, 2006, Pages 1113-1116

  Derk, Chris T ^a,b,d   Rasheed, Mehmoodur ^a,c   Artlett, Carol M ^a   Jimenez, Sergio A ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b Department of Medicine ^*

^c Holter Clinic   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Cancer; Incidence; Malignancy; Scleroderma; Systemic sclerosis; Tissue fibrosis

Indexed keywords

CYCLOPHOSPHAMIDE; METHOTREXATE; PENICILLAMINE;

ADULT; ARTICLE; CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; COMPARATIVE STUDY; ESOPHAGUS CANCER; FEMALE; FIBROSIS; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; OROPHARYNX CANCER; PRIORITY JOURNAL; SEX DIFFERENCE; STANDARDIZATION; SYSTEMIC SCLEROSIS;

COHORT STUDIES; COMORBIDITY; INCIDENCE; NEOPLASMS; PENNSYLVANIA; REGISTRIES; SCLERODERMA, SYSTEMIC;

EID: 33744742312     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Jimenez SA, Derk CT. Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis. Ann Intern Med 2004;140:37-50.
2. Tuffanelli DL, Winkelmann RK. Systemic scleroderma: a clinical study of 727 cases. Arch Dermatol 1961;84:359-71.
3. Farmer RG, Gifford RW, Hines EA. Prognostic significance of Raynaud's phenomenon and other clinical characteristics of systemic scleroderma: a study of 271 cases. Circulation 1960;21:1088-95.
4. Duncan SC, Winkelmann RK. Cancer and scleroderma. Arch Dermatol 1979;115:950-5.
5. Peters-Golden M, Wise RA, Hochberg M, et al. Incidence of lung cancer in systemic sclerosis. J Rheumatol 1985;12:1136-9.
6. Roumm AD, Medsger TA. Cancer and systemic sclerosis: an epidemiologic study. Arthritis Rheum 1985;28:1336-40.
7. Abu Shakra M, Guillemin F, Lee P. Cancer in systemic sclerosis. Arthritis Rheum 1993;36:460-4.
8. Rosenthal AK, McLaughlin JK, Gridley G, Nyren O. Incidence of cancer among patients with systemic sclerosis. Cancer 1995;76:910-4.
9. Hill CL, Nguyen A-M, Roder D, Roberts-Thompson P. Risk of cancer in patients with scleroderma: a population based cohort study. Ann Rheum Dis 2003;62:728-31.
10. Chatterjee S, Dombi GW, Severson RK, May es MD. Risk of malignancy in scleroderma: a population-based cohort study. Arthritis Rheum 2005;52:2415-24.
11. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
12. Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Database: Incidence - SEER 9 Regs Public-Use, Nov 2002 Sub (1973-2002), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2003, based on the November 2002 submission. Available from http://www.seer.cancer.gov
13. Breslow NE, Day NE. Statistical methods in cancer research. Volume II: The design and analysis of cohort studies. IARC Sci Publ 1987;82:1-406.
14. Derk CT, Rasheed M, Spiegel JR, et al. Increased incidence of carcinoma of the tongue in patients with systemic sclerosis. J Rheumatol 2005;32:637-41.